NCT02500212View on ClinicalTrials.gov

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Organ or Tissue Transplant; Complications
Interventions
DRUG

ENVARSUS®

DRUG

ADVAGRAF®

Trial Locations (7)

31400

CHU Rangueil, 1 avenue J Poulhes TSA 50032., Toulouse

34295

Service de Nephrologie, Montpellier

38043

Clinique de Nephrologie CHU Grenoble, Grenoble

42055

Nephrology department CHU de Saint-Etienne Hospital Nord, Saint-Etienne

87042

CHU Limoges, Limoges

296009

Nephrology Department Hopital La Cavale Blanche, Brest

Unknown

Unité de transplantation rénale -Hopital Pasteur, Nice

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT02500212 - Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients | Biotech Hunter | Biotech Hunter